NAD+ vs NMN: coenzyme vs precursor
NAD+ vs NMN is one of the most searched comparisons in longevity research. NAD+ (nicotinamide adenine dinucleotide) is the coenzyme itself — present in every cell, required for energy metabolism and consumed by sirtuins and PARP enzymes. NMN (nicotinamide mononucleotide) is a precursor: cells convert it into NAD+ through the salvage pathway. Animal studies report that NAD+ levels decline with age, which is why both molecules are studied in aging and metabolism research. PeptidesDirect supplies NAD+ as ≥99% purity lyophilised powder for laboratory research use only; we do not sell NMN.
Side-by-side comparison
| NAD+ | NMN | |
|---|---|---|
| What it is | Dinucleotide coenzyme — the active molecule cells use | Nucleotide precursor — converted into NAD+ inside cells |
| Role | Carries electrons in energy metabolism; substrate for sirtuins and PARPs | Intermediate in the NAD+ salvage pathway |
| Molecular weight | 663.43 g/mol | 334.22 g/mol |
| Research focus | Direct replenishment of cellular NAD+ in lab models | Raising NAD+ indirectly via oral precursor administration |
| Cell entry | Charged dinucleotide; generally thought to be broken down extracellularly before uptake | Converted to NR outside cells, or taken up via the proposed Slc12a8 transporter |
| Human trial evidence | Limited; most human work uses precursors | Several small, short randomised trials (laboratory endpoints) |
| Sold by PeptidesDirect | Yes — 100mg and 750mg vials, research use only | No |
What is NAD+?
NAD+ is a dinucleotide coenzyme found in every living cell. It shuttles electrons in the reactions that convert nutrients into cellular energy, and it is consumed as a substrate by sirtuins and PARP enzymes, linking it to DNA repair and cellular stress responses (Verdin, 2015).
Despite being stocked by peptide suppliers, NAD+ is not a peptide — it contains no amino acids. It is two nucleotides joined by a phosphate bridge.
What is NMN?
NMN (nicotinamide mononucleotide) is a single nucleotide: nicotinamide, a ribose sugar and one phosphate group. It is roughly half the size of NAD+ (334 vs 663 g/mol) and is the direct building block the cell adds an adenine nucleotide to when it makes NAD+.
Like NAD+, NMN is not a peptide. It is studied as a precursor — a way of feeding the NAD+ pool — rather than as an active signalling molecule in its own right.
How NMN becomes NAD+: the salvage pathway
Most cellular NAD+ is recycled through the salvage pathway. NAMPT converts nicotinamide into NMN — the rate-limiting step — and NMNAT enzymes then convert NMN into NAD+ (Revollo et al., 2004). Supplying NMN therefore bypasses the NAMPT step.
Covarrubias et al. (2021) review how the de novo, Preiss-Handler and salvage routes contribute differently across tissues, which is why the same precursor can produce different effects in different model systems.
- Nicotinamide → NMN, via NAMPT (rate-limiting).
- NMN → NAD+, via NMNAT1–3 (nucleus, Golgi/cytosol, mitochondria).
- Nicotinamide riboside → NMN, via NRK1/2.
How each molecule gets into cells
Neither molecule simply diffuses in. Ratajczak et al. (2016) reported that in mammalian cells extracellular NMN is largely converted to nicotinamide riboside, taken up, and re-phosphorylated by NRK1. Grozio et al. (2019) later proposed Slc12a8 as a dedicated NMN transporter in mouse small intestine; that finding is still debated in the literature.
NAD+ is a larger, charged molecule, and extracellular NAD+ is generally thought to be degraded to smaller precursors before uptake. This is the main reason oral-supplement research favours precursors while direct NAD+ is used where delivery is controlled, such as cell culture and in-vitro assays.
Animal research
In mice, NMN improved glucose tolerance and insulin sensitivity in diet- and age-induced diabetes models (Yoshino J et al., 2011). Long-term NMN administration in mice mitigated age-associated physiological decline across measures including body weight gain, energy metabolism and insulin sensitivity (Mills et al., 2016).
A 2018 Cell Metabolism review summarised the in-vivo evidence for NAD-boosting molecules, most of it generated with precursors such as NMN and nicotinamide riboside (Rajman et al., 2018). One proposed reason NAD+ falls with age is rising consumption by CD38 (Camacho-Pereira et al., 2016).
Human research
A single-dose safety study in healthy Japanese men reported that oral NMN was tolerated and raised nicotinamide metabolite levels (Irie et al., 2020). A 10-week randomised trial in prediabetic women reported increased muscle insulin sensitivity (Yoshino M et al., 2021), and a randomised trial in amateur runners reported changes in measures of aerobic capacity (Liao et al., 2021).
These trials are small, short and report laboratory or physiological measures. Comparable controlled human data for direct NAD+ are limited.
Why researchers compare them
The practical question in the literature is whether to supply the coenzyme directly or supply a precursor and let the cell convert it. Direct NAD+ gives a defined amount of the end molecule in a controlled system; NMN relies on the cell's own uptake and NMNAT activity, which vary by tissue.
The choice therefore depends on the model: in-vitro enzyme or sirtuin assays usually call for NAD+ itself, while whole-organism precursor studies have mostly used NMN or nicotinamide riboside.
What has not been established
No head-to-head human trial has compared NAD+ with NMN. The human NMN data cover weeks, not years, and do not establish long-term clinical outcomes. Mouse findings, particularly on lifespan and ageing, have not been shown to translate to humans.
How NMN enters cells is itself unresolved, and tissue NAD+ measurements are technically difficult — both limit how confidently results can be compared between studies.
Frequently asked questions
What is the difference between NAD+ and NMN?
NAD+ is the coenzyme cells actually use; NMN is a precursor that cells convert into NAD+ through the salvage pathway. They are different molecules with different roles in research.
Is NMN a peptide?
No. Like NAD+, NMN is a nucleotide, not a peptide. Neither contains amino acids.
Is NAD+ a peptide?
No. NAD+ is a dinucleotide coenzyme. See the NAD+ research guide /learn/nad-plus-research-guide for why it is sold alongside peptides.
How does NMN turn into NAD+?
NMNAT enzymes add an adenine nucleotide to NMN to form NAD+. In the salvage pathway, NMN itself is made from nicotinamide by NAMPT, the rate-limiting step.
What is the difference between NMN and NR?
Nicotinamide riboside (NR) lacks NMN's phosphate group. Cells phosphorylate NR into NMN via NRK enzymes, and extracellular NMN is often converted to NR before uptake.
Can NAD+ enter cells directly?
NAD+ is large and charged, and extracellular NAD+ is generally thought to be broken down into smaller precursors before uptake. This is why direct NAD+ is mostly used in controlled in-vitro systems.
Is there an NMN transporter?
Grozio et al. (2019) proposed Slc12a8 as an NMN transporter in mouse intestine. The finding is still debated, and other work shows NMN is converted to NR before entering cells.
Which has more human research, NAD+ or NMN?
Most published human trials have used precursors such as NMN and nicotinamide riboside rather than NAD+ itself. Direct NAD+ is more common in laboratory and in-vitro research.
What have human NMN trials found?
Small, short trials report tolerability, raised NAD+ metabolites, increased muscle insulin sensitivity in prediabetic women, and changes in aerobic capacity measures in runners. Long-term outcomes are not established.
Has NAD+ been compared head-to-head with NMN?
Not in a published human trial. Comparisons rely on separate studies with different designs and endpoints.
Does PeptidesDirect sell NMN?
No. We supply NAD+ in 100mg and 750mg vials for laboratory research only. See our research peptides guide research peptides guide for how to compare suppliers and read test documents.
How should NAD+ be stored?
Keep lyophilised NAD+ cold, dry and protected from light. NAD+ in solution is sensitive to heat and alkaline pH, so prepare it fresh, refrigerate it and avoid repeated freeze-thaw cycles.
Is this product for human use?
No. PeptidesDirect sells this compound for laboratory research only. It is not a drug, food or cosmetic and is not for human or veterinary use. This page summarises published research and is not dosing or medical guidance.
Shop the compounds covered in these FAQs: NAD+ 100mg / 750mg
References
- Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015. PubMed 26785480
- Covarrubias AJ, et al. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021. PubMed 33353981
- Revollo JR, et al. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004. PubMed 15381699
- Ratajczak J, et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nat Commun. 2016. PubMed 27725675
- Grozio A, et al. Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab. 2019. PubMed 31131364
- Yoshino J, et al. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011. PubMed 21982712
- Mills KF, et al. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab. 2016. PubMed 28068222
- Rajman L, et al. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018. PubMed 29514064
- Camacho-Pereira J, et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016. PubMed 27304511
- Irie J, et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J. 2020. PubMed 31685720
- Yoshino M, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021. PubMed 33888596
- Liao B, et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. J Int Soc Sports Nutr. 2021. PubMed 34238308
Research compounds
Related guides
- NAD+ vs NMN Research: Evidence Summary
- NAD+ research guide
- SS-31 research guide
- Research peptides guide
- Reconstitution guide
- Storage guide
Research Use Only. Not for human or veterinary use. Not dosing or medical guidance.
